Location: Home
  • search
  • go
  • Relate News
  • 11/27/2018China Approved 30 New Drugs from Foreign Countries in the Past 21 Mont...
  • 11/27/2018Hikma Pharma to Sell Hansoh Pharma's Injectable Anticancers in the U.S...
  • 11/27/2018AiPing Pharma Strikes Ibuprofen Deal with Xinhua Pharma
  • 11/26/2018Gene-Edited Babies: China Wants To Be The World Leader, But At What Co...
  • 11/26/2018China Pins Its Hopes on Beating US in Race for Bio-Intelligence Suprem...
  • 11/26/2018CBT Pharma and Bossan Pharma Enter into License Agreement to Develop C...
  • 11/26/2018NHC and SATCM Issue New Pharmacy Service Policy, Banning Contract Mana...
  • 11/26/2018CPA: Review of Chinese Hospital Drug Market Changes in the Past Five Y...
  • 11/26/2018NHC: HIV/AIDS Rate at Low Level in China
  • 11/26/2018Chi-Med and Eli Lilly Announce First Commercial Launch of Fruquintinib...
  • 11/23/2018Recent Executive Moves
  • 11/23/2018MOFCOM Solicits Comments on Draft Guidelines for National Classificati...
  • 11/23/2018National Pharmacopoeia Commission Solicits Comments on Guide for Gener...
  • 11/22/2018CDE Solicits Comments on Guideline for Clinical Research of Age-Relate...
  • 11/22/2018Trump Administration Accuses China of Unfairly Using Venture Capital t...
  • 11/22/2018HitGen and Biogen enter a DNA-Encoded Library-Based Drug Discovery Res...
  • 11/20/2018Ascletis and Roche Enter Exclusive Pegasys Partnership in China for Vi...
  • 11/20/2018Sanofi China to Open New $114M Research Site in Suzhou
  • 11/20/2018NMPA Issues Notice for Implementation of State Council’s “Permit and...
  • 11/20/2018Alphamab raises $100M in Series A financing from US, Asian investors
  • 11/19/2018Huadong Medicine Completes Acquisition of U.K.'s Sinclair Pharma
  • 11/19/2018CASI Pharmaceuticals To Build GMP Manufacturing Site In Wuxi
  • 11/19/2018CCDRC Approves Plan for National Centralized Drug Purchase Trial
  • 11/19/2018NH Reports on Chinese OTC Eye Care Market in MAT 09/2018
  • 11/19/2018Eli Lilly Mulls Sale of Certain Off-patent CNS and Antibiotic Assets i...
  • 11/16/2018NMPA Approves Gilead's Vemlidy (Tenofovir Alafenamide) in China
  • 11/16/2018Chi-Med Announces Negative Results of Phase III Chinese Trial for Fruq...
  • 11/16/2018NMPA Grants Priority Review to BeiGene's NDAs for Zanubrutinib and Tis...
  • 11/15/2018How China Will Handle Its Trade War With the United States in 2019
  • 11/15/2018MorphoSys and I-Mab Enter Strategic Alliance for MorphoSys's Novel I/O...
  • Page:307/779 Total number of articles:23361: [First][<<] [305] [306] [307] [308] [309] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group